Diego Casas-Deza

30PUBLICATIONS
184CO-AUTHORS
Cancer geneticsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 27, 2026
Real-World Germline Testing Patterns and Clinical Implications of HRR-Associated Germline Variants in Pancreatic Ductal Adenocarcinoma.

|Aug 12, 2026
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

|Jul 29, 2026
Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU.

|Jan 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz

|Dec 18, 2025
Effect of vedolizumab treatment on extraintestinal articular manifestations in patients with inflammatory bowel disease: meta-analysis.

Diego Casas-Deza, Carmen Yagüe-Caballero, Camila Cuarán Cetina

|Aug 28, 2025
Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.

Diego Casas-Deza, Santiago García-López, Vanesa Bernal-Monterde

Pageof 5

Frequent Collaborators

11 joint publications

José Miguel Arbonés-Mainar

6 joint publications

Carmen Yagüe-Caballero

6 joint publications

Vanesa Bernal-Monterde

5 joint publications

Yamile Zabana